(AMRN) Amarin - Performance -40.9% in 12m
Compare AMRN with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-94.52%
#197 in Group
Rel. Strength
14.94%
#6768 in Universe
Total Return 12m
-40.85%
#93 in Group
Total Return 5y
-93.40%
#124 in Group
P/E -
(?) Percentile in Group
P/E Forward 500
96th Percentile in Group
PEG -1.74
13th Percentile in Group
FCF Yield -48.73%
72th Percentile in Group
12m Total Return: AMRN (-40.9%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
2.95% | 13.3% | 161% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
12.6% | 32.2% | 49.3% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-8.67% | -12.4% | 27.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
15.8% | 12% | 33.5% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
4.68% | 18.2% | -1.63% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
14.1% | 27.3% | -5.64% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
21.4% | -17.2% | 1.88% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
22.4% | 0.59% | 8.05% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: AMRN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for AMRN
| Total Return (including Dividends) | AMRN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 13.57% | 2.02% | 2.87% |
| 3 Months | -0.55% | -15.44% | -6.42% |
| 12 Months | -40.85% | -14.02% | 9.87% |
| 5 Years | -93.40% | -26.47% | 107.51% |
| Trend Score (consistency of price movement) | AMRN | XBI | S&P 500 |
| 1 Month | 64.0% | 57% | 89.4% |
| 3 Months | -27.2% | -82.3% | -72% |
| 12 Months | -85.8% | -53.1% | 49.3% |
| 5 Years | -96.0% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #24 | 11.3% | 10.4% |
| 3 Month | #61 | 17.6% | 6.26% |
| 12 Month | #93 | -31.2% | -46.2% |
| 5 Years | #132 | -91.0% | -96.8% |
FAQs
Does AMRN Amarin outperforms the market?
No,
over the last 12 months AMRN made -40.85%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.02%.
Over the last 3 months AMRN made -0.55%, while XBI made -15.44%.
Over the last 3 months AMRN made -0.55%, while XBI made -15.44%.
Performance Comparison AMRN vs Indeces and Sectors
AMRN vs. Indices AMRN is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -4.15% | 10.7% | -1.90% | -50.7% |
| US NASDAQ 100 | QQQ | -4.40% | 8.86% | -2.31% | -52.2% |
| US Dow Jones Industrial 30 | DIA | -4.43% | 12.0% | -0.87% | -47.2% |
| German DAX 40 | DAX | -6.27% | -5.71% | -27.5% | -65.9% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -4.81% | 7.30% | -1.13% | -46.5% |
| Hongkong Hang Seng | HSI | -7.67% | -2.64% | -11.4% | -52.9% |
| India NIFTY 50 | INDA | -1.76% | 11.3% | -3.80% | -43.2% |
| Brasil Bovespa | EWZ | -6.20% | 2.04% | -11.1% | -34.4% |
AMRN vs. Sectors AMRN is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -4.33% | 9.90% | -8.08% | -61.2% |
| Consumer Discretionary | XLY | -5.07% | 10.1% | 0.29% | -54.9% |
| Consumer Staples | XLP | -3.78% | 11.6% | -8.81% | -48.4% |
| Energy | XLE | -5.13% | 13.5% | 4.10% | -31.1% |
| Financial | XLF | -4.78% | 8.0% | -7.78% | -62.4% |
| Health Care | XLV | -0.36% | 18.0% | 3.33% | -34.9% |
| Industrial | XLI | -5.72% | 6.19% | -2.88% | -50.8% |
| Materials | XLB | -4.14% | 8.86% | 2.15% | -34.8% |
| Real Estate | XLRE | -3.82% | 7.45% | -4.28% | -54.3% |
| Technology | XLK | -5.04% | 6.83% | 0.37% | -47.9% |
| Utilities | XLU | -5.19% | 7.95% | -9.67% | -56.8% |
| Aerospace & Defense | XAR | -4.66% | 4.23% | -11.2% | -66.0% |
| Biotech | XBI | 3.93% | 11.6% | 19.2% | -26.8% |
| Homebuilder | XHB | -3.71% | 10.5% | 11.7% | -31.1% |
| Retail | XRT | -4.30% | 9.98% | 4.39% | -36.5% |